Ghost Tree Capital’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Ghost Tree Capital’s Portfolio CYNA Stock Details CYNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-151,535	Closed	-$1.8M	–	90
2016 Q1	$1.8M	Sell	151,535 -95	-0.1%	-$1.27K	1.02%	36
2015 Q4	$2.32M	Sell	151,630 -23,370	-13%	-$355K	0.95%	36
2015 Q3	$2.83M	Sell	175,000 -87,696	-33%	-$1.42M	1.27%	32
2015 Q2	$4.28M	Buy	+262,696	New	+$4.31M	1.39%	32

Other funds holding CYNA

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Ghost Tree Capital's CYNA Position: Q2 2016 in Review

Ghost Tree Capital sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q2 2016, closing a stake of 151,535 shares — an estimated $1.8M sold.

Ghost Tree Capital first reported a position in CYNA in Q2 2015 and held it in 4 quarters. The position peaked at $4.28M in Q2 2015. 32 funds tracked by Wall St. Rank hold CYNA as of Q2 2016.

Ghost Tree Capital reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q2 2016 after selling out during the quarter.
Ghost Tree Capital sold 151,535 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q2 2016, an estimated $1.8M.
Ghost Tree Capital first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q2 2015 and held it in 4 quarters.
Ghost Tree Capital's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $4.28M in Q2 2015.
32 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q2 2016.

Based on Ghost Tree Capital's 13F filing for Q2 2016, filed 12 Aug 2016.